Product Description
Alfadex also known as alpha-cyclodextrin, is used as an inactive ingredient in order to improve the water solubility of the different drugs, e.g. edex: is a sterile, pyrogen-free powder containing alprostadil in an alfadex inclusion complex. (Sourced from: https://drugs.ncats.io/drug/Z1LH97KTRM)
Mechanisms of Action: EP1 Analogue
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Austria | Colombia | Japan | Korea | Pakistan | Taiwan | Turkey
Approved Indications: None
Known Adverse Events: None
Company: SFI Research
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Overweight|Obesity|Prediabetes
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT03002168 |
FMAT | N/A |
Completed |
Healthy Volunteers |
2017-06-05 |
2019-03-21 |
Treatments |
|
NCT02999620 |
FMAT | N/A |
Completed |
Healthy Volunteers |
2017-06-01 |
2019-03-21 |
Treatments |
|
NCT01910558 |
FAT ABSORBER | N/A |
Withdrawn |
Obesity |
2013-10-01 |
2019-03-19 |
Treatments |
|
ACTRN12614001302640 |
ACTRN12614001302640 | P3 |
Completed |
Prediabetes|Overweight|Obesity |
2018-03-22 |
2026-02-15 |
Treatments |